STOCK TITAN

[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) disclosed a Form 4 showing a director acquired 1,057 shares of common stock on 10/23/2025 via transaction code M, reflecting the settlement of restricted stock units into shares.

Following the transaction, the director beneficially owned 7,698 common shares directly. The filing also shows 2,115 restricted stock units beneficially owned after the event, with vesting scheduled at 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026. The derivative security price is listed as $0, consistent with RSU settlement.

USANA Health Sciences (USNA) ha reso pubblico un Modulo 4 che mostra che un amministratore ha acquisito 1.057 azioni ordinarie il 23/10/2025 tramite il codice di transazione M, riflettendo lo scioglimento di unità azionarie vincolate in azioni.

Dopo la transazione, l'amministratore deteneva beneficiariamente 7.698 azioni ordinarie direttamente. La dichiarazione mostra anche 2.115 unità azionarie vincolate beneficiariamente detenute dopo l'evento, con l'acquisizione prevista al 25% il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026. Il prezzo dello strumento derivato è indicato come $0, coerente con il regolamento delle RSU.

USANA Health Sciences (USNA) divulgó un Formulario 4 que muestra que un administrador adquirió 1.057 acciones ordinarias el 23/10/2025 mediante el código de transacción M, reflejando el asentamiento de unidades de acciones restringidas en acciones.

Después de la transacción, el administrador poseía beneficiosamente 7.698 acciones ordinarias directamente. El documento también muestra 2.115 unidades de acciones restringidas beneficiosamente poseídas tras el evento, con el vesting programado al 25% el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026, y 23 de abril de 2026. El precio del instrumento derivado figura como $0, consistente con el acuerdo de RSU.

USANA Health Sciences (USNA) 이사회 이사 한 명이 1,057주 보통주2025년 10월 23일에 거래 코드 M로 취득했다는 Form 4를 공개했습니다. 이는 제한 주식 단위가 주식으로 해결된 것을 반영합니다.

거래 후 이사는 직접적으로 7,698주 보통주를 유익하게 소유했습니다. 제출서는 또한 2,115주 제한 주식 단위가 행사 후 유익하게 보유되며, vesting은 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 각각 25%로 예정되어 있음을 보여줍니다. 파생증권의 가격은 $0로 기재되어 RSU 결제와 일치합니다.

USANA Health Sciences (USNA) a divulgué un formulaire 4 montrant qu'un administrateur a acquis 1 057 actions ordinaires le 23/10/2025 via le code de transaction M, reflétant le règlement d'unités d'actions restreintes en actions.

Suite à la transaction, l'administrateur détenait bénéficiairement 7 698 actions ordinaires directement. Le dépôt indique également 2 115 unités d'actions restreintes détenues de manière bénéficiaire après l'événement, avec le vesting prévu à 25% le 24 juillet 2025, 23 octobre 2025, 22 janvier 2026, et 23 avril 2026. Le prix de l'instrument dérivé est indiqué comme $0, conforme au règlement des RSU.

USANA Health Sciences (USNA) machte ein Formular 4 bekannt, das zeigt, dass ein Direktor 1.057 Stammaktien am 23.10.2025 über den Transaktionscode M erworben hat, was der Abwicklung von Restricted Stock Units in Aktien entspricht.

Nach der Transaktion besaß der Direktor direkt 7.698 Stammaktien unmittelbar vorteilhaft. Die Einreichung zeigt zudem 2.115 Restricted Stock Units vorteilhaft nach dem Ereignis, mit der Vesting-Planung von 25% am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026. Der Preis des Derivate-Instruments ist mit $0 angegeben, konsistent mit der RSU-Abwicklung.

USANA Health Sciences (USNA) كشفت عن نموذج 4 يُظهر أن أحد المديرين اشترى 1,057 سهماً عادياً في 23/10/2025 عبر رمز الصفقة M، ما يعكس تسوية وحدات الأسهم المقيدة إلى أسهم.

بعد الصفقة، امتلك المدير بشكل مستفيد 7,698 سهماً عادياً مباشرة. تُظهر الإبلاغ أيضاً 2,115 وحدة أسهم مقيدة مقيدة مستفاداً بعد الحدث، مع جدولة الاستحقاق عند 25% في 24 يوليو 2025، 23 أكتوبر 2025، 22 يناير 2026، و23 أبريل 2026. سعر الأداة المشتقة مُسجّل كـ $0، ومتسق مع تسوية RSU.

Positive
  • None.
Negative
  • None.

USANA Health Sciences (USNA) ha reso pubblico un Modulo 4 che mostra che un amministratore ha acquisito 1.057 azioni ordinarie il 23/10/2025 tramite il codice di transazione M, riflettendo lo scioglimento di unità azionarie vincolate in azioni.

Dopo la transazione, l'amministratore deteneva beneficiariamente 7.698 azioni ordinarie direttamente. La dichiarazione mostra anche 2.115 unità azionarie vincolate beneficiariamente detenute dopo l'evento, con l'acquisizione prevista al 25% il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026. Il prezzo dello strumento derivato è indicato come $0, coerente con il regolamento delle RSU.

USANA Health Sciences (USNA) divulgó un Formulario 4 que muestra que un administrador adquirió 1.057 acciones ordinarias el 23/10/2025 mediante el código de transacción M, reflejando el asentamiento de unidades de acciones restringidas en acciones.

Después de la transacción, el administrador poseía beneficiosamente 7.698 acciones ordinarias directamente. El documento también muestra 2.115 unidades de acciones restringidas beneficiosamente poseídas tras el evento, con el vesting programado al 25% el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026, y 23 de abril de 2026. El precio del instrumento derivado figura como $0, consistente con el acuerdo de RSU.

USANA Health Sciences (USNA) 이사회 이사 한 명이 1,057주 보통주2025년 10월 23일에 거래 코드 M로 취득했다는 Form 4를 공개했습니다. 이는 제한 주식 단위가 주식으로 해결된 것을 반영합니다.

거래 후 이사는 직접적으로 7,698주 보통주를 유익하게 소유했습니다. 제출서는 또한 2,115주 제한 주식 단위가 행사 후 유익하게 보유되며, vesting은 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일에 각각 25%로 예정되어 있음을 보여줍니다. 파생증권의 가격은 $0로 기재되어 RSU 결제와 일치합니다.

USANA Health Sciences (USNA) a divulgué un formulaire 4 montrant qu'un administrateur a acquis 1 057 actions ordinaires le 23/10/2025 via le code de transaction M, reflétant le règlement d'unités d'actions restreintes en actions.

Suite à la transaction, l'administrateur détenait bénéficiairement 7 698 actions ordinaires directement. Le dépôt indique également 2 115 unités d'actions restreintes détenues de manière bénéficiaire après l'événement, avec le vesting prévu à 25% le 24 juillet 2025, 23 octobre 2025, 22 janvier 2026, et 23 avril 2026. Le prix de l'instrument dérivé est indiqué comme $0, conforme au règlement des RSU.

USANA Health Sciences (USNA) machte ein Formular 4 bekannt, das zeigt, dass ein Direktor 1.057 Stammaktien am 23.10.2025 über den Transaktionscode M erworben hat, was der Abwicklung von Restricted Stock Units in Aktien entspricht.

Nach der Transaktion besaß der Direktor direkt 7.698 Stammaktien unmittelbar vorteilhaft. Die Einreichung zeigt zudem 2.115 Restricted Stock Units vorteilhaft nach dem Ereignis, mit der Vesting-Planung von 25% am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026. Der Preis des Derivate-Instruments ist mit $0 angegeben, konsistent mit der RSU-Abwicklung.

USANA Health Sciences (USNA) كشفت عن نموذج 4 يُظهر أن أحد المديرين اشترى 1,057 سهماً عادياً في 23/10/2025 عبر رمز الصفقة M، ما يعكس تسوية وحدات الأسهم المقيدة إلى أسهم.

بعد الصفقة، امتلك المدير بشكل مستفيد 7,698 سهماً عادياً مباشرة. تُظهر الإبلاغ أيضاً 2,115 وحدة أسهم مقيدة مقيدة مستفاداً بعد الحدث، مع جدولة الاستحقاق عند 25% في 24 يوليو 2025، 23 أكتوبر 2025، 22 يناير 2026، و23 أبريل 2026. سعر الأداة المشتقة مُسجّل كـ $0، ومتسق مع تسوية RSU.

USANA Health Sciences (USNA) 披露了一份 Form 4,显示一名董事在 2025/10/23 通过交易代码 M 获得 1,057股普通股,这反映了限制性股票单位结转为股票的结算。

交易后,该董事直接实际持有 7,698股普通股。申报还显示在事件后实际持有 2,115单位受限股票,授予期限将于 2025年7月24日2025年10月23日2026年1月22日2026年4月23日 分别以 25% 进行解锁。衍生证券的价格被列为 $0,与 RSU 的结算一致。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Nixon J Scott

(Last) (First) (Middle)
3838 WEST PARKWAY BLVD.

(Street)
SALT LAKE CITY UT 84120

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/23/2025 M 1,057 A (1) 7,698 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/23/2025 M 1,057 (2) (2) Common Stock 1,057 $0 2,115 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did USANA (USNA) report in this Form 4?

A director acquired 1,057 common shares on 10/23/2025 via transaction code M, indicating RSU conversion.

How many USANA shares does the reporting person own after the transaction?

The reporting person beneficially owned 7,698 common shares directly after the transaction.

What derivative holdings remain after the transaction for USNA?

The filing shows 2,115 restricted stock units beneficially owned following the transaction.

What is the vesting schedule for the reported USANA RSUs?

RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

What does transaction code M signify in the USNA Form 4?

Code M indicates the exercise or conversion of a derivative security, here the settlement of RSUs into common stock.

Was a price paid for the derivative security conversion?

The derivative security price is listed as $0, consistent with RSU settlement mechanics.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

358.31M
10.40M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY